(6) Eric Topol auf Twitter: "New @TheLancet: @AstraZeneca vaccine vs B.1.1.7 strain (and non-B.1.1.7) in > 8500 participants w/ > 200,000 nose/ throat swabs https://t.co/1qsyvnJP9u Efficacy: Symptomatic B.1.1.7: 70%; other 82% Asymptomatic B.1.1.7:29%; other 70% https://t.co/oTQX9f9IbQ" / Twitter
Covid19-Sources
ARS - Antibiotika Resistenz Surveillance
outbreak.info
COVID-19: the risk to BAME doctors
Long Covid: More than 1 million experiencing symptoms in UK, official data shows | The Independent
The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents - The New York Times
The American Journal of Public Health (AJPH) from the American Public Health Association (APHA) publications
CoVariants
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine
Diurnal variation in SARS-CoV-2 PCR test results: Test accuracy may vary by time of day | medRxiv
Jeder zweite beatmete COVID-19-Patient während der zweiten Coronawelle...
Understanding the effectiveness of government interventions in Europe’s second wave of COVID-19 | medRxiv
RKI - Coronavirus SARS-CoV-2 - Übersicht und Empfehlungen zu besorgniserregenden SARS-CoV-2-Virusvarianten (VOC)
Aktualisierter Bericht zu Virusvarianten von SARS-CoV-2 in Deutschland, insbesondere zur Variant of Concern (VOC) B.1.1.7 - Bericht_VOC_2021-03-24.pdf
Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study, England | medRxiv
Latest updates: COVID-19 vaccination charts, maps and eligibility by country
The emerging plasticity of SARS-CoV-2 | Science
Analysis of Excess Deaths During the COVID-19 Pandemic in the State of Florida | AJPH | Vol. 111 Issue 4
Reconciling estimates of global spread and infection fatality rates of COVID‐19: an overview of systematic evaluations - Ioannidis - - European Journal of Clinical Investigation - Wiley Online Library
(3) Dr Nisreen Alwan 🌻 auf Twitter: "THREAD 1/ Our #LongCovid survey findings are now out. I want to express sincere thanks to all the participants. This study is from & for you. Apologies for the delay in reporting due to limited time & capacity but here we are (preprint, not peer reviewed) https://t.co/y7l60hqYnf https://t.co/iHSQYC1bT3" / Twitter
SARS‐CoV‐2 re‐infection risk in Austria - Pilz - 2021 - European Journal of Clinical Investigation - Wiley Online Library
Dirk Brockmann: "Die Leute begreifen, dass sie die Pandemie selbst bekämpfen müssen" | ZEIT ONLINE
The infection fatality rate of COVID-19 inferred from seroprevalence data | medRxiv
Spotlight on the dark figure: Exhibiting dynamics in the case detection ratio of COVID-19 infections in Germany | medRxiv
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. - 2021.03.18.21253888v2.full.pdf
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers” - Graham - - Annals of Clinical and Translational Neurology - Wiley Online Library
Upplýsingar um COVID-19 og bólusetningu á Íslandi
Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine - 2021.01.29.21250653v1.full.pdf
Impffortschritt. Nach dem ja die Impfkampagne schon 2… | by Thomas Strub | Mar, 2021 | Medium
A convergence based assessment of relative differences in age-stratified susceptibility and infectiousness for SARS-CoV-2 variants of B.1.1.7 lineage - 2021.03.18.21253931v1.full.pdf